Hiran Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.85 M
as on 23-10-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.80 M
as on 23-10-2024
- Satisfied Charges ₹ 3.84 M
as on 23-10-2024
- Revenue 598.33%
(FY 2023)
- Profit 1389.52%
(FY 2023)
- Ebitda 57.78%
(FY 2023)
- Net Worth 163.58%
(FY 2023)
- Total Assets 19.81%
(FY 2023)
About Hiran Diagnostics
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.85 M.
The company currently has active open charges totaling ₹1.80 M. The company has closed loans amounting to ₹3.84 M, as per Ministry of Corporate Affairs (MCA) records.
Kanika Sharma, Nidhi Sharma, and Nikhil Sharma serve as directors at the Company.
- CIN/LLPIN
U85195RJ1995PTC009495
- Company No.
009495
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hiran Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanika Sharma  | Director | 18-Mar-2010 | Current |
| Nidhi Sharma | Director | 15-Mar-2011 | Current |
| Nikhil Sharma | Director | 15-Mar-2011 | Current |
Financial Performance of Hiran Diagnostics.
Hiran Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 598.33% increase. The company also saw a substantial improvement in profitability, with a 1389.52% increase in profit. The company's net worth Soared by an impressive increase of 163.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hiran Diagnostics?
In 2023, Hiran Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ge Capital Services India Creation Date: 27 Dec 2007 | ₹1.80 M | Open |
The Bank Of Rajasthan Ltd. Creation Date: 18 Oct 2003 | ₹3.40 M | Satisfied |
The Bank Of Rajasthan Ltd. Creation Date: 21 Jun 1999 | ₹0.24 M | Satisfied |
How Many Employees Work at Hiran Diagnostics?
Unlock and access historical data on people associated with Hiran Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hiran Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hiran Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
